Preferred Label : heparin, low-molecular-weight;

MeSH definition : Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of hemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism.;

MeSH synonym : low-molecular-weight heparin; low molecular weight heparin; lmwh; heparin, low molecular weight;

MeSH annotation : /antag probably HEPARIN ANTAGONISTS; DF: note short X ref; /antag probably HEPARIN ANTAGONISTS;

Wikipedia link : https://en.wikipedia.org/wiki/Low-molecular-weight heparin;

Is substance : O;

Details


Main resources

You can consult :

Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of hemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism.

https://minerva-ebp.be/FR/Article/2337
2023
Belgium
critical appraisal or critical reading
acetylsalicylic acid
wounds and injuries
Trauma
heparin
snacks
injury, nos
heparin, low-molecular-weight
aspirin

---
https://www.cochrane.org/fr/CD006649/GYNAECA_anticoagulants-dans-le-traitement-initial-des-caillots-sanguins-chez-les-personnes-atteintes-dun
2021
false
false
false
France
United Kingdom
neoplasms
venous thromboembolism
heparin
heparin, low-molecular-weight
treatment outcome
anticoagulotherapy
meta-analysis
french abstract
anticoagulants

---
https://www.cochrane.org/fr/CD008500/PVD_la-prevention-des-caillots-sanguins-chez-les-patients-atteints-de-cancer-non-hospitalises-recevant
2020
false
false
false
United Kingdom
France
neoplasms
antineoplastic agents
ambulatory care
treatment outcome
anticoagulants
heparin, low-molecular-weight
vitamin K
aspirin
warfarin
apixaban
semuloparin
anticoagulotherapy
meta-analysis
french abstract
venous thromboembolism
pyrazoles
pyridones

---
https://www.has-sante.fr/portail/jcms/c_2899631/fr/innohep
2019
false
false
false
France
evaluation of the transparency committee
innohep
heparin, low-molecular-weight
Tinzaparin

---
http://www.cochrane.org/fr/CD007557/lheparine-non-fractionnee-versus-les-heparines-de-bas-poids-moleculaire-pour-eviter-la
2017
false
true
false
United Kingdom
France
postoperative period
heparin
review of literature
french abstract
thrombocytopenia
heparin, low-molecular-weight

---
http://www.cochrane.org/fr/CD002001/les-antagonistes-de-la-vitamine-k-ou-lheparine-de-bas-poids-moleculaire-pour-le-traitement-long
2017
false
United Kingdom
France
French
anticoagulotherapy
meta-analysis
vitamin K
heparin, low-molecular-weight
anticoagulants
fibrinolytic agents
venous thromboembolism
treatment outcome
french abstract

---
https://www.jle.com/fr/revues/abc/e-docs/suivi_biologique_de_lheparinotherapie_interet_clinique_et_aspects_pratiques__308387/article.phtml
10.1684/abc.2016.1198
2016
false
false
false
France
French
journal article
heparin
heparin
continuity of patient care
practice guidelines as topic
heparin, low-molecular-weight
thromboembolism
thromboembolism
anticoagulants
anticoagulants
injections
blood coagulation tests
Anti-Factor Xa Activity Measurement
platelet count
partial thromboplastin time
whole blood coagulation time
pregnancy
obesity
renal insufficiency
adult
infant, newborn
child
heparin-induced thrombocytopenia
argatroban
bivalirudin
pediatric obesity
danaparoid
polysaccharides
pipecolic acids
hirudins
peptide fragments
recombinant proteins
dermatan sulfate
heparitin sulfate
chondroitin sulfates
Fondaparinux

---
https://minerva-ebp.be/FR/Article/2056
2016
false
false
false
Belgium
French
french abstract
atrial fibrillation
heparin, low-molecular-weight
anticoagulants
preoperative care
thromboembolism
hemorrhage
vitamin K
Elective Surgical Procedures

---
http://www.cochrane.org/fr/CD004179/les-anticoagulants-pris-sur-des-durees-prolongees-pour-prevenir-la-thrombose-veineuse-profonde-ou
2016
false
false
false
France
United Kingdom
French
review of literature
french abstract
treatment outcome
venous thrombosis
pulmonary embolism
anticoagulants
drug administration schedule
arthroplasty, replacement, hip
hip prosthesis
arthroplasty, replacement, knee
knee prosthesis
postoperative complications
heparin, low-molecular-weight
vitamin K
anticoagulants
femoral neck fractures
chemoprevention

---
http://www.cochrane.org/fr/CD006681
2014
false
false
false
United Kingdom
France
treatment outcome
chemoprevention
adult
anticoagulants
leg injuries
anticoagulotherapy
meta-analysis
french abstract
venous thromboembolism
heparin, low-molecular-weight
leg
immobilization

---
http://www.cochrane.org/fr/CD003462
2014
false
false
false
France
United Kingdom
acute coronary syndrome
treatment outcome
heparin, low-molecular-weight
anticoagulants
anticoagulotherapy
meta-analysis
french abstract
heparin

---
https://www.cochrane.org/fr/CD005982/anticoagulants-pour-la-prevention-des-caillots-sanguins-chez-les-enfants-avec-un-catheter-veineux-central
2014
false
false
false
France
United Kingdom
review of literature
french abstract
venous thrombosis
catheterization, central venous
treatment outcome
heparin, low-molecular-weight
chemoprevention
anticoagulotherapy
anticoagulants
child
central venous catheters

---
https://minerva-ebp.be/fr/article/25
2014
false
false
minerva-ebm.be
Belgium
French
aspirin
anticoagulants
thromboembolism
treatment outcome
arthroplasty, replacement, hip
hip prosthesis
heparin, low-molecular-weight
critical appraisal or critical reading
anticoagulotherapy
comparative study

---
http://www.cochrane.org/fr/CD006650
2014
false
false
false
France
United Kingdom
neoplasms
heparin, low-molecular-weight
treatment outcome
vitamin K
ximelagatran
antithrombins
venous thromboembolism
administration, oral
anticoagulotherapy
meta-analysis
french abstract
venous thromboembolism
anticoagulants

---
http://www.cochrane.org/fr/CD009447
2013
false
true
false
United Kingdom
France
neoplasms
thromboembolism
heparin
treatment outcome
meta-analysis
french abstract
heparin, low-molecular-weight

---
http://www.cochrane.org/fr/CD006421
2013
United Kingdom
France
French
review of literature
meta-analysis
heparin, low-molecular-weight
anticoagulants
intravitreal injections
fluorouracil
vitreoretinopathy, proliferative
postoperative complications
retinal detachment
ophthalmologic surgical procedures
comparative study
treatment outcome
anticoagulotherapy

---
http://www.has-sante.fr/portail/jcms/c_1625647/en/label-de-la-has-thromboses-arterielles-et-veineuses-dans-le-cadre-de-lassistance-medicale-a-la-procreation-amp-prevention-et-prise-en-charge
http://www.agence-biomedecine.fr/IMG/pdf/argumentaire_amp_thromboses.pdf
2013
true
France
French
anticoagulotherapy
consensus
venous thromboembolism
thrombosis
reproductive techniques, assisted
THROMBOSIS ARTERIAL
arteries
venous thromboembolism
thrombosis
reproductive techniques, assisted
venous thrombosis
venous thrombosis
risk factors
pregnancy
pregnancy complications, cardiovascular
stroke
anticoagulants
heparin, low-molecular-weight

---
http://www.cochrane.org/fr/CD010155
2013
United Kingdom
France
French
review of literature
heparin, low-molecular-weight
anemia, sickle cell
arterial occlusive diseases
treatment outcome
french abstract

---
https://minerva-ebp.be/fr/analyses-en-ligne/154
2013
false
false
minerva-ebm.be
Belgium
French
Dutch
recurrence
antivitamins K
critical appraisal or critical reading
secondary prevention
venous thromboembolism
heparin, low-molecular-weight
antivitamins K
treatment outcome
warfarin
meta-analysis as topic
indenes
4-hydroxycoumarins
vitamin K
comparative study
indenes
4-hydroxycoumarins

---
http://www.cochrane.org/fr/CD003074
2013
false
United Kingdom
France
French
meta-analysis
heparin, low-molecular-weight
venous thromboembolism
treatment outcome
drug administration schedule
french abstract

---
http://www.cochrane.org/fr/CD004982
2012
United Kingdom
France
French
anticoagulotherapy
meta-analysis
thrombophlebitis
leg
treatment outcome
anti-inflammatory agents, non-steroidal
anticoagulants
heparin, low-molecular-weight
venous thromboembolism
french abstract
Thrombophlebitis leg superficial

---
http://www.cochrane.org/fr/CD001100
2011
false
true
false
United Kingdom
France
heparin
treatment outcome
heparin
review of literature
french abstract
heparin, low-molecular-weight
venous thromboembolism

---
http://www.cochrane.org/fr/CD005981
2011
false
true
false
United Kingdom
France
arthroplasty
treatment outcome
review of literature
french abstract
antithrombins
vitamin K
venous thromboembolism
heparin, low-molecular-weight

---
https://www.jle.com/fr/revues/bio_rech/jpc/e-docs/00/04/69/82/resume.phtml
2011
France
French
anticoagulotherapy
renal insufficiency
heparin, low-molecular-weight
anticoagulants
journal article
venous thromboembolism

---
http://www.cochrane.org/fr/CD006774
2011
United Kingdom
France
French
anticoagulotherapy
meta-analysis
colitis, ulcerative
heparin
heparin, low-molecular-weight
remission induction
treatment outcome
anticoagulants
french abstract

---
https://www.jle.com/fr/revues/medecine/gpn/e-docs/00/04/68/23/resume.phtml
2011
France
French
anticoagulotherapy
guideline adherence
residential facilities
anticoagulants
heparin, low-molecular-weight
journal article
aged

---
https://smf.swisshealthweb.ch/fr/article/doi/fms.2011.07451/
2011
false
true
false
Switzerland
heparin
thromboembolism
neoplasms
heparin, low-molecular-weight
journal article
heparin

---
http://www.cochrane.org/fr/CD002132
2010
false
true
false
France
United Kingdom
heparin
acute coronary syndrome
treatment outcome
review of literature
french abstract
heparin, low-molecular-weight

---
http://www.aboutkidshealth.ca/Fr/HealthAZ/Drugs/Pages/Tinzaparin.aspx
2010
false
Canada
French
English
heparin, low-molecular-weight
child
heparin, low-molecular-weight
tinzaparin
injections, subcutaneous
fibrinolytic agents
fibrinolytic agents
heparin, low-molecular-weight
drug information
patient education handout
Tinzaparin
Tinzaparin

---
https://minerva-ebp.be/fr/article/430
2009
false
minerva-ebm.be
Belgium
French
stockings, compression
arthroscopy
knee joint
postoperative complications
venous thromboembolism
heparin, low-molecular-weight
venous thrombosis
fibrinolytic agents
pulmonary embolism
treatment outcome
critical appraisal or critical reading

---
https://pgtmsite.files.wordpress.com/2024/01/heparine_securite_pgtm_20090308.pdf
2009
Canada
drug information
Heparin Measurement
safety
Safety
heparin
heparin, low-molecular-weight
Heparin
Safety Study
heparin

---
https://ansm.sante.fr/uploads/2021/03/11/ae4209ebc36d7164d4b7c876ddeaabab.pdf
2009
true
France
French
antivitamins K
anticoagulotherapy
venous thromboembolism
venous thrombosis
stockings, compression
heparin
heparin, low-molecular-weight
stroke
fibrinolytic agents
aspirin
intracranial hemorrhages
thrombosis
catheterization
neoplasms
venous thrombosis
pulmonary embolism
acute disease
ambulatory care
venous thromboembolism
anticoagulants
time
vitamin K
vena cava filters
anticoagulants
antivitamins K
antivitamins K
practice guideline
indenes
4-hydroxycoumarins

---
https://www.jle.com/fr/revues/medecine/stv/e-docs/00/04/2F/7F/resume.md
2007
France
French
antivitamins K
anticoagulotherapy
practice guidelines as topic
pregnancy
heparin, low-molecular-weight
anticoagulants
postoperative care
vitamin K
thromboembolism
heart valve prosthesis
antivitamins K
journal article
practice guideline
indenes
4-hydroxycoumarins

---
http://www.fmoq.org/Lists/FMOQDocumentLibrary/fr/Le%20M%C3%A9decin%20du%20Qu%C3%A9bec/Archives/2000%20-%202009/077-080info-comprimee0906.pdf
2006
Canada
French
anticoagulotherapy
administration, oral
anticoagulants
heparin, low-molecular-weight
risk assessment
preoperative care
postoperative care
quebec
risk factors
thrombosis
postoperative hemorrhage
injections, subcutaneous
journal article

---
http://sfar.org/?p=6550
http://sfar.org/prevention-de-la-maladie-thromboembolique-veineuse-perioperatoire-et-obstetricale/
2005
true
France
French
anticoagulotherapy
fibrinolytic agents
venous thromboembolism
venous thromboembolism
heparin
heparin, low-molecular-weight
treatment outcome
postoperative complications
orthopedic procedures
risk assessment
wounds and injuries
surgical procedures, operative
chemoprevention
ambulatory surgical procedures
heparin
heparin, low-molecular-weight
anticoagulants
anticoagulants
arthroscopy
knee injuries
digestive system surgical procedures
esophageal and gastric varices
urologic surgical procedures
gynecologic surgical procedures
risk factors
obstetric surgical procedures
pregnancy
thrombophilia
thoracic surgical procedures
vascular surgical procedures
cardiac surgical procedures
neurosurgical procedures
spinal injuries
burns
fibrinolytic agents
Evidence-Based medicine
practice guideline

---
http://www.john-libbey-eurotext.fr/fr/revues/medecine/stv/e-docs/00/04/06/67/resume.md?type=text.html
http://www.john-libbey-eurotext.fr/fr/revues/medecine/stv/e-docs/00/04/06/67/telecharger.md?code_langue=fr&format=application/pdf&titre=Version PDF
http://www.john-libbey-eurotext.fr/fr/revues/medecine/stv/e-docs/00/04/06/67/article.md?type=text.html
2004
France
French
journal article
practice guideline
antivitamins K
anticoagulotherapy
anticoagulants
aged
aspirin
risk factors
vitamin K
heparin, low-molecular-weight
anticoagulants
hemorrhage
international normalized ratio
continuity of patient care
age factors
anticoagulants
platelet aggregation inhibitors
platelet aggregation inhibitors
Contraindications, Procedure
Contraindications, Drug
anticoagulants
anticoagulants
heparin, low-molecular-weight
patient education as topic
embolism and thrombosis
embolism and thrombosis
hemorrhage
fibrinolytic agents
fibrinolytic agents
fibrinolytic agents
fibrinolytic agents
fibrinolytic agents
heparin, low-molecular-weight
heparin, low-molecular-weight
heparin, low-molecular-weight
antivitamins K
antivitamins K
indenes
4-hydroxycoumarins

---
http://www.has-sante.fr/portail/display.jsp?id=c_272236
2003
France
French
anticoagulotherapy
thromboembolism
thromboembolism
thrombophilia
hematoma
eclampsia
pregnancy complications, cardiovascular
fetal growth retardation
fetal death
blood chemical analysis
hematologic tests
communication
pregnancy
thrombophilia
risk factors
risk assessment
population characteristics
placenta diseases
heparin
heparin
heparin, low-molecular-weight
heparin, low-molecular-weight
infant, newborn
fetus
thromboembolism
anticoagulants
anticoagulants
fibrinolytic agents
fibrinolytic agents
thrombocytopenia
osteoporosis
thrombophilia
heparin
heparin, low-molecular-weight
anticoagulants
fibrinolytic agents
aspirin
aspirin
pregnancy complications, hematologic
consensus

---
https://www.hug.ch/sites/interhug/files/structures/pharmacie/infos-medic/cappinfo/cappinfo24.pdf
2003
Switzerland
journal article
barium sulfide
aged
inpatients
heparin, low-molecular-weight

---
http://www.ulb.ac.be/esp/gras/hbpm.html
1999
Belgium
French
anticoagulants
fibrinolytic agents
heparin, low-molecular-weight
heparin, low-molecular-weight
practice guideline

---
Nous contacter.
26/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.